Literature DB >> 22999237

Glycemic variability and glycemic control in the acutely ill cardiac patient.

Jared Moore1, Kathleen Dungan.   

Abstract

The mechanisms for hyperglycemia-mediated harm in the hospitalized cardiac patient are poorly understood. Potential obstacles in the inpatient management of hyperglycemia in cardiac patients include rapidly changing clinical status, frequent procedures and interruptions in carbohydrate exposure, and short hospital length of stay. A patient's preadmission regimen is rarely suitable for inpatient glycemic control. Instead, an approach to a flexible, physiologic insulin regimen is described, which is intended to minimize glycemic excursions. When diabetes or hyperglycemia is addressed early and consistently, the hospital stay can serve as a potential window of opportunity for reinforcing self-care behaviors that reduce long-term complications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999237      PMCID: PMC3756484          DOI: 10.1016/j.hfc.2012.06.006

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  147 in total

1.  Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.

Authors:  S D Anker; A L Clark; M Kemp; C Salsbury; M M Teixeira; P G Hellewell; A J Coats
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

2.  Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.

Authors:  John G Canto; Catarina I Kiefe; William J Rogers; Eric D Peterson; Paul D Frederick; William J French; C Michael Gibson; Charles V Pollack; Joseph P Ornato; Robert J Zalenski; Jan Penney; Alan J Tiefenbrunn; Philip Greenland
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

3.  Admission glycaemia and outcome after acute coronary syndrome.

Authors:  P Petursson; J Herlitz; K Caidahl; S Gudbjörnsdottir; T Karlsson; E Perers; H Sjöland; M Hartford
Journal:  Int J Cardiol       Date:  2006-07-18       Impact factor: 4.164

Review 4.  Glucagon-like peptide analogues for type 2 diabetes mellitus.

Authors:  Deepson S Shyangdan; Pamela Royle; Christine Clar; Pawana Sharma; Norman Waugh; Alisa Snaith
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  Increasing blood glucose variability heralds hypoglycemia in the critically ill.

Authors:  Rondi M Kauffmann; Rachel M Hayes; Brad D Buske; Patrick R Norris; Thomas R Campion; Marcus Dortch; Judith M Jenkins; Bryan R Collier; Addison K May
Journal:  J Surg Res       Date:  2011-03-31       Impact factor: 2.192

Review 6.  Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.

Authors:  Paul E Marik; Jean-Charles Preiser
Journal:  Chest       Date:  2009-12-16       Impact factor: 9.410

7.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Authors:  R Feinstein; H Kanety; M Z Papa; B Lunenfeld; A Karasik
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.

Authors:  C L Gaboury; D C Simonson; E W Seely; N K Hollenberg; G H Williams
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Computer-assisted glucose control in critically ill patients.

Authors:  Mathijs Vogelzang; Bert G Loef; Joost G Regtien; Iwan C C van der Horst; Hein van Assen; Felix Zijlstra; Maarten W N Nijsten
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

View more
  4 in total

1.  Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.

Authors:  Marcus Hompesch; Aleksandra Hawryluk; Moises Hernandez; Beena Uchil; Alyssa Wilmington; Lucas Peterson
Journal:  Diabetes Obes Metab       Date:  2021-09-08       Impact factor: 6.408

2.  New digital tool to facilitate subcutaneous insulin therapy orders: an inpatient insulin dose calculator.

Authors:  Marcos Tadashi Kakitani Toyoshima; Alexandre Barbosa Câmara de Souza; Sharon Nina Admoni; Priscilla Cukier; Simão Augusto Lottenberg; Ana Claudia Latronico; Márcia Nery
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

Review 3.  Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.

Authors:  Joyce N Njoroge; John R Teerlink
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

4.  Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency.

Authors:  Fawad Ahmad Randhawa; Saqib Mustafa; Dur Muhammad Khan; Shahid Hamid
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.